Skip to main content

Table 3 Outcomes of neonates treated with LED phototherapy

From: Risk factors for acute bilirubin encephalopathy on admission to two Myanmar national paediatric hospitals

 

Hospital A

Hospital B

n = 251

n = 339

Exchange transfusionsa

  

 n (%)

38 (15.3 %)

88 (26.0 %)

 TSB (μmol/L) at ET: Median (IQR)b

474 (416–539)

500 (475–513)

Duration of treatment (days): Median (IQR)c

2.0 (1.0-2.0)

1.0 (1.0-2.0)

Discharge status

  

 Discharged: n (%)

221 (88.1 %)

276 (81.4 %)

 Removed by family: n (%)

3 (1.2 %)

8 (2.4 %)

 Died: n (%)

18 (7.2 %)

38 (11.2 %)

 Transferred to other hospital: n (%)

0 (0.0 %)

2 (0.6 %)

 CBEd: n (%)

5 (2.0 %)

5 (1.5 %)

 Not stated: n (%)

4 (1.6 %)

10 (3.0 %)

  1. n number, IQR Interquartile range (25th percentile – 75th percentile)
  2. aAt Hospital A, data missing on exchange transfusion status of three records
  3. bTSB at ET missing for 12 transfused neonates at Hospital A and for 42 transfused neonates at Hospital B; note that most readings at Hospital B were performed on equipment with a maximum reading of 513 μmol/L
  4. cDuration of treatment unavailable for 22 records at Hospital A and 84 records at Hospital B
  5. d‘Kernicterus’ is the term routinely used in both hospitals; in this situation it is assumed to refer to CBE